Surrey Heartlands

Joint Formulary & PAD

Macrogol compound - Faecal impaction (children)

You are here : Home > Formulary Search > Macrogol compound - Faecal impaction (children)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Sachets (powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Prescribe as macrogol compound half-strength oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
 

Status 2

Red
Formulations :
  • Sachets (powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Moviprep. Off-label for faecal impaction. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
 

Status 3

Red
Formulations :
  • Sachets (powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Plenvu. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Macrogol compound
Indication :
Faecal impaction (children)
Group Name :
Keywords :
Brand Names Include :
Laxido paediatric, Movicol paediatric, CosmoCol paediatric, Moviprep, Plenvu
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Macrogol compound is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Faecal impaction (children).

Committee Recommendations (1)

03 Jul 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.